Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$720,000 |
 |
AmarinAMRN |
$520,000 |
 |
Gilead SciencesGILD |
-$3.24B |
 |
AmgenAMGN |
-$168M |
 |
Editas MedicineEDIT |
-$8.5M |
Are Tempest Therapeutics Insiders Buying or Selling?
Tempest Therapeutics (TPST) has had no reported insider transactions in the past 90 days. The most recent was Matthew Angel, who bought 231,482 shares at $2.16 on March 24, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the TPST AI Score. For government officials trading this stock, see TPST congressional trading.
Who’s Trading Tempest Therapeutics Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| Versant Ventures IV, LLC | Sold $970,000 | 2 | Aug 12, 2024 |
| Matthew Angel | Bought $500,000 | 2 | Mar 24, 2026 |
Recent Tempest Therapeutics Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Matthew Angel | Mar 24, 2026 | Buy | 231,482 | $2.16 | $500,000 |
| Matthew Angel | Mar 24, 2026 | Buy | 231,482 | $0 | $0 |
| Versant Ventures IV, LLC | Aug 12, 2024 | Sell | 387,999 | $1.1 | $430,000 |
| Versant Ventures IV, LLC | Aug 8, 2024 | Sell | 400,000 | $1.35 | $540,000 |
Frequently Asked Questions: Tempest Therapeutics Insider Trading
Tempest Therapeutics insiders have not reported any transactions in the past 90 days.
The most recent sale was by Versant Ventures IV, LLC who sold 387,999 shares on August 12, 2024. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
Angel Matthew has bought the most TPST stock in the last 2 years, with a total value of $500,000.
Versant Ventures IV, LLC has sold the most TPST stock in the last 2 years, with a total value of $970,000.
The total value of insider transactions for Tempest Therapeutics in the last 2 years is negative, amounting to -$470,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
